SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DIACOUSTIC MEDICAL DEVICES (PTY)
VS
by Kestra Medical Technologies

AI Verdict

Tool A, SENSICARDIAC MOBI, is an AI-powered mobile application designed to assist physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. In contrast, Tool B, ASSURE Wearable ECG, is a non-therapeutic wearable device for continuous heart rate monitoring and data collection for at-risk cardiac patients. While both leverage AI in cardiology, Tool A focuses on point-of-care murmur diagnosis, whereas Tool B provides ongoing remote patient surveillance through ECG monitoring.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if you are a physician needing immediate, AI-powered assistance during a patient examination to differentiate between physiological and pathological heart murmurs. This tool is ideal for point-of-care clinical decision support in cardiology, internal medicine, or pediatrics, helping to quickly identify and categorize suspected murmurs based on acoustic heart signals.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require continuous, long-term heart rate monitoring and data collection for at-risk cardiac patients outside of a clinical setting. This wearable device and integrated platform are best suited for remote patient management, providing clinicians with automatic episode storage, alert-based notifications, and physiologic trend data for comprehensive oversight of cardiac health over time.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION ASSURE Wearable ECG
Pricing Contact for pricing Contact for pricing.
Deployment Hosted server environment (Linux OS) with a mobile application interface Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool B, with its wearable device and SensorFit Garment designed for patient comfort and continuous, passive monitoring, offers a higher degree of usability for long-term data collection. Tool A, while mobile, requires active engagement from a physician with a separate stethoscope during an examination, making it more of a point-of-care diagnostic tool rather than a continuously usable patient-facing solution.

Clinical Value

ASSURE Wearable ECG

Tool B provides continuous heart rate monitoring, physiologic trend data, and alert-based notifications, offering a proactive and comprehensive approach to managing at-risk cardiac patients over time. While Tool A offers valuable point-in-time diagnostic assistance for heart murmurs, Tool B's ongoing insights and early detection capabilities for at-risk patients present a broader and potentially more impactful clinical value for patient management.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact for details. Without publicly available pricing information or detailed value propositions beyond their features, it is impossible to conduct a meaningful comparison of their pricing or overall value for money.

Enterprise Readiness

Tie

Both tools explicitly state HIPAA compliance and the presence of a Business Associate Agreement (BAA), which are crucial for enterprise adoption in healthcare. Their deployment models (hosted server environment for Tool A, cloud-based platform for Tool B) are standard for enterprise solutions, and neither provides specific details on advanced integration capabilities or scalability to differentiate them further.

Innovation

ASSURE Wearable ECG

Tool B demonstrates significant innovation through its comprehensive wearable system, including the SensorFit Garment, Quad Channel Processing, and Adaptive Patient Intelligence for robust motion artifact filtering in continuous monitoring. While Tool A's AI-powered mobile murmur diagnosis is innovative, Tool B's advanced signal processing and integrated wearable design for real-world, continuous data collection present a more complex and novel solution in its domain.

Support & Docs

Tie

The provided structured facts and subsequent web searches did not yield specific, publicly available information regarding detailed support services, service level agreements, or comprehensive documentation portals for either tool. Therefore, based on the available data, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION ASSURE Wearable ECG
Product Name SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION ASSURE Wearable ECG
Company DIACOUSTIC MEDICAL DEVICES (PTY) Kestra Medical Technologies
Primary Function Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds. Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into a digital healthcare platform for at-risk cardiac patients.
Target Specialties Cardiology, Internal Medicine, Pediatrics Cardiology
Key Feature: Analysis/Monitoring Type AI-powered analysis of acoustic heart signals; distinguishes between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs. Continuous heart rate monitoring; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts; automatic episode storage; alert-based notifications; physiologic trend data.
Key Feature: Data Collection Method Acquires and records acoustic heart signals from a user-provided compatible electronic stethoscope via a mobile application. Wearable ECG device with SensorFit Garment featuring non-adhesive, embedded, and cushioned ECG sensors.

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

SensiCardiac Mobi is a mobile application that integrates into the physical examination workflow by analyzing acoustic heart signals from an electronic stethoscope in real-time to assist in diagnosing heart murmurs. In contrast, the ASSURE Wearable ECG is a wearable device for continuous heart rate monitoring, with data collected and reviewed remotely through the Kestra CareStation platform, fitting into a remote patient monitoring workflow.
SensiCardiac Mobi utilizes an AI-powered algorithm to distinguish between normal and pathological heart murmurs, identifying S1, S2, and suspected murmurs to support physician assessment. The ASSURE Wearable ECG features an ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence to filter motion artifacts, providing accurate continuous heart rate monitoring and automatic episode storage.
SensiCardiac Mobi is suitable for Cardiology, Internal Medicine, and Pediatrics, assisting in the diagnosis of heart murmurs across a broad patient base. The ASSURE Wearable ECG is designed for Cardiology, specifically for continuous heart rate monitoring and data collection in at-risk cardiac patients.
SensiCardiac Mobi involves using a mobile application with a compatible electronic stethoscope to record heart sounds at specific auscultation positions, suggesting a relatively straightforward integration into existing physical exam routines. The ASSURE Wearable ECG requires understanding the application of the SensorFit Garment for continuous monitoring and navigating the Kestra CareStation remote patient data platform for reviewing patient data.
SensiCardiac Mobi's deployment involves a mobile application and user-provided electronic stethoscopes, which could facilitate rollout across multiple sites with individual device provisioning. ASSURE Wearable ECG requires the distribution of wearable devices to patients and access to the cloud-based Kestra CareStation platform for clinicians across different locations.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.